Er:Yag Laser Treatment of Simple Snorers in an Outpatient Setting


CETINKAYA E. A., TURKER M., KIRAZ K., Gulkesen H. K.

ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, cilt.78, sa.2, ss.70-76, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1159/000443510
  • Dergi Adı: ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.70-76
  • Anahtar Kelimeler: Snoring, Er:YAG laser, Laser treatment, OBSTRUCTIVE SLEEP-APNEA, ASSISTED UVULOPALATOPLASTY
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objective: Snoring occurs as a result of soft tissue vibration caused by a partial upper airway collapse during sleep. This study evaluated the effectiveness and potential adverse side effects associated with the use of a nonsurgical, erbium-doped yttrium aluminum garnet (Er:YAG) laser treatment for patients with snoring conditions. Materials and Methods: In total, 33 patients with different degrees of snoring were analyzed retrospectively. All patients received three Night-Lase (TM) Er:YAG laser treatments. Results were measured using a follow-up questionnaire and then statistically analyzed. Any effects that occurred during the first year after treatment (i.e., short-term effects) were followed up with interviews. Results: Laser treatment effectively reduced patients' snoring and achieved a 65% satisfaction rate after three treatments. The greatest improvement and satisfaction were experienced by patients aged >= 50 years. Patients reported additional benefits from this treatment including easier breathing, higher alertness, and increased focus. Conclusion: Nonsurgical Er:YAG laser treatment is an effective and minimally invasive procedure to reduce patient snoring and other sleep-disordered breathing symptoms. Patients reported minimal disadvantages including minor discomfort and a low risk of side effects. (C) 2016 S. Karger AG, Basel